Wolberg Kirsten O.
Known title: DirectorCIK: 0001664367
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
RBC Lowers SLM Price Target to $28, Maintains Outperform. RBC Capital has lowered its price target for SLM Corporation to $28 while keeping an Outperform rating. The stock is currently trading near its 52-week low, which aligns with a recent technical signal confirming support at $22.34. This move reflects cautious sentiment among analysts regarding the company's near-term outlook.
Transaction History
| DT | ▲ Buy | Option Exercise | 4,111 | — | 8/20/2026 | View on chart |
| SLM | ▲ Buy | Grant | 7,349 | $0 | 6/16/2026 | View on chart |
| DT | ▲ Buy | Option Exercise | 3,981 | — | 8/20/2025 | View on chart |
| SLM | ▲ Buy | Grant | 5,281 | $0 | 6/17/2025 | View on chart |
| SLM | ▼ Sell | Gift | 4,665 | $0 | 6/9/2025 | View on chart |
| DT | ▲ Buy | Grant | 3,981 | $0 | 8/23/2024 | View on chart |
| SLM | ▲ Buy | Grant | 7,069 | $0 | 6/18/2024 | View on chart |
| DT | ▲ Buy | Grant | 4,290 | $0 | 8/23/2023 | View on chart |
| SLM | ▲ Buy | Grant | 7,589 | $0 | 6/21/2023 | View on chart |
| DT | ▲ Buy | Grant | 5,190 | $0 | 8/24/2022 | View on chart |
| SLM | ▲ Buy | Grant | 7,971 | $0 | 6/21/2022 | View on chart |
| DT | ▲ Buy | Grant | 3,010 | $0 | 8/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Dynatrace Completes Arize Acquisition, UBS Raises Target to $74
Dynatrace has finished acquiring Arize to expand its AI observability capabilities across the development lifecycle. UBS responded by raising its price target to $74, citing potential growth in the AI sector. The stock is currently trading near its 52-week high, with an RSI of 71.9 suggesting it may be overbought.
Dynatrace Completes Arize Acquisition, UBS Raises Target to $74. Dynatrace has finished acquiring Arize to expand its AI observability capabilities across the development lifecycle. UBS responded by raising its price target to $74, citing potential growth in the AI sector. The stock is currently trading near its 52-week high, with an RSI of 71.9 suggesting it may be overbought.